Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer  

作　　者：Jun-Hao Huang Wei Guo Zhe Liu 

机构地区：[1]Department of Pancreatic-Biliary Surgery,The First Hospital of China Medical University,Shenyang 110001,Liaoning Province,China

出　　处：《World Journal of Gastroenterology》2023年第3期579-581,共3页世界胃肠病学杂志（英文版）

摘　　要：Pancreatic cancer is a malignant tumor with poor prognosis.The treatment of pancreatic cancer depends on the tumor stage and type,and includes local treatment(surgery,radiotherapy and ablation intervention)and systemic therapy(chemotherapy,targeted therapy and immunotherapy).We read with great interest the review“Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment”published on World J Gastroenterol and intended to share some of our perspectives in pancreatic cancer treatment.This review presents the therapeutic effects of the combination of gemcitabine and targeted drugs,which gives us a deeper insight into the combination treatments for pancreatic cancer.

关 键 词：Pancreatic cancer CHEMOTHERAPY Targeted therapy GEMCITABINE DRUG COMBINATION 

分 类 号：R735.9[医药卫生—肿瘤]